Sigrid Baumgartner

Delineation of target expression profiles in CD34+/CD38− and CD34+/CD38+ stem and progenitor cells in AML and CML

Harald Herrmann, Irina Sadovnik, Gregor Eisenwort et al. · Blood Advances · 2020 · 105 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia

Sabine Cerny‐Reiterer, Anja Rabenhorst, Gabriele Stefanzl et al. · Oncotarget · 2014 · 54 citations · Full text

Medicine, Hematology, Oncology +16

Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): an investigator-initiated, randomized, multi-center, multi-national, clinical trial on additional cerebral tissue oxygen saturation monitoring combined with defined treatment guidelines versus standard monitoring and treatment as usual in premature infants during immediate transition: study protocol for a randomized controlled trial

Gerhard Pichler, Sigrid Baumgartner, Marlene Biermayr et al. · Trials · 2019 · 41 citations · Full text

Medicine, Pediatrics, Infant Health +16

The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells

Barbara Peter, Sabine Cerny‐Reiterer, Emir Hadzijusufovic et al. · Journal of Leukocyte Biology · 2013 · 35 citations

Medicine, Oncology, Pharmacology +12

Preterm infants who later require duct ligation show different vital signs and pH in early postnatal life

Manuel Steiner, Ulrike Salzer‐Muhar, Vanessa Swoboda et al. · Acta Paediatrica · 2014 · 13 citations

Public Health, Child Health, Pediatrics +17